Adaptin Bio (APTN) Total Non-Current Liabilities (2025 - 2026)
Adaptin Bio recorded quarterly Total Non-Current Liabilities of $1.9 million in Q1 2026, up 23.96% quarter-over-quarter from $1.6 million in Q4 2025, and up 246.28% year-over-year from $557471.0 in Q1 2025.
Adaptin Bio's Total Non-Current Liabilities history runs 2 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 246.28% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (up 246.28% YoY), while the FY2025 annual figure was $1.6 million, changed N/A from the prior year.
- Total Non-Current Liabilities came in at $1.9 million for Q1 2026 at Adaptin Bio, up from $1.6 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $1.9 million in Q1 2026 to a low of $557471.0 in Q1 2025.
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.93 Mn |
| Dec 31, 2025 | 1.56 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 636,957.00 |
| Mar 31, 2025 | 557,471.00 |